Wednesday, July 26, 2023



Department of Justice News: Thoroughbred Racehorse Trainer Jason Servis Sentenced To Four Years In Prison


Department of Justice News: Thoroughbred Racehorse Trainer Jason Servis Sentenced To Four Years In Prison

Damian Williams, the United States Attorney for the Southern District of New York, announced that defendant JASON SERVIS was sentenced to four years in prison today for his role in a years-long scheme in which horses trained by SERVIS were doped with approved and unapproved drugs designed to improve the performance of SERVIS’s racehorses, in connection with the charges filed in United States v. Navarro et al., 20 Cr. 160 (MKV). SERVIS was one of over 30 defendants charged in four separate cases in March 2020, each arising from this Office’s multi-year investigation of the abuse of racehorses through the use of performance enhancing drugs (“PEDs”).

Monday, July 10, 2023


Amendments to the Food and Drug Regulations ...

4 hours ago — A new regulatory framework to address commercial compounding is being developed with the aim to fill a current gap in regulatory oversight.


The Wholesaling Prohibition (Potentially) Demystified? ...

5 days ago — Under section 503B, drugs compounded by an FDA-registered outsourcing facility under the supervision of a licensed pharmacist can qualify for exemptions ..


US FDA Provides Recommendations on the Statutory ...

1 day ago — US FDA Provides Recommendations on the Statutory Prohibition on Wholesaling for Certain Compounded Drugs ... According to FDA, this draft guidance describes the 


July 2023 – Resolutions | Ohio Board of Pharmacy

4 days ago — As used in this resolution “originating facility” means the facility where compounded medication administration occurs and “compounding facility” means the .


Pharmacy Inspection Deficiency Monetary Penalty Guide

5 days ago — 20b. Pharmacist not documenting verification of accuracy of sterile compounding process and integrity of compounded products. 54.1-3410.2,. 18VAC110-20-355.


Compounding warning letters to 503A facilities between ...

by Q Zhang2023 — The content of warning letter violations was analyzed in terms of both the compounding environment and 503A facilities that did not received valid prescriptions .


Novo Nordisk sues 4 more companies for making illegal ...

3 hours ago — In federal courts in Florida and Tennessee, Novo Nordisk has accused four pharmacies of making unauthorized compounded versions of Ozempic and Wegovy.